vimarsana.com

Page 424 - ஒன்றுபட்டது மாநிலங்களில் மாவட்டம் நீதிமன்றம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Deadline in 5 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Class Action

Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Canaan Inc (CAN)

Share: RADNOR, Pa., May 02, 2021 (GLOBE NEWSWIRE) The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Southern District of New York against Canaan Inc. (NASDAQ:CAN) ( Canaan ) on behalf of those who purchased or acquired Canaan American Depositary Receipts ( ADRs ) between February 10, 2021 and April 9, 2021, inclusive (the Class Period ). Investor Deadline Reminder: Investors who purchased or acquired Canaan ADRs during the Class Period may, no later than June 14, 2021 , seek to be appointed as a lead plaintiff representative of the class. For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq. (484) 270-1453 or Adrienne Bell, Esq. (484) 270-1435; toll free at (844) 887-9500; via e-mail atinfo@ktmc.com;

Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in . Kessler Topaz Meltzer & Check LLPMay 2, 2021 GMT RADNOR, Pa., May 02, 2021 (GLOBE NEWSWIRE) The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Western District of Washington against CytoDyn Inc. (OTCMKTS: CYDY) (“CytoDyn”) on behalf of those who purchased or acquired CytoDyn common stock between March 27, 2020 and March 9, 2021, inclusive (the “Class Period”). Deadline Reminder: Investors who purchased or acquired CytoDyn common stock

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.